Pranlukast

From Wikipedia, the free encyclopedia

Pranlukast chemical structure
Pranlukast
Systematic (IUPAC) name
N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-7-yl]-
4-(4-phenylbutoxy)benzamide
Identifiers
CAS number  ?
ATC code R03DC02
PubChem 115100
Chemical data
Formula C27H23N5O4 
Mol. weight 481.503 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism Hepatic (mainly CYP3A4)[1]
Half life 1.5 hours[1]
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes Oral

Pranlukast is a cysteinyl leukotriene receptor-1 antagonist. This drug works similarly to Merck & Co.'s Singulair (montelukast).

Medications of this class, which go under a variety of names according to whether one looks at the American, British or European system of nomenclature, have as their primary function the antagonism of bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.

Medications of this group are normally used as an adjunct to the standard therapy of inhaled steroids with inhaled long- and/or short-acting beta-agonists. There are several similar medications in the group; all appear to be equally effective.

[edit] References

  1. ^ a b Nakade S, Ueda S, Ohno T, Nakayama K, Miyata Y, Yukawa E, Higuchi S (2006). "Population pharmacokinetics of pranlukast hydrate dry syrup in children with allergic rhinitis and bronchial asthma.". Drug Metab Pharmacokinet 21 (2): 133-9. PMID 16702733.


Medications commonly used in asthma and COPD (primarily R03) edit
Anticholinergics:

Ipratropium, Tiotropium

Short acting β2-agonists:

Salbutamol, Terbutaline

Long acting β2-agonists (LABA): Clenbuterol, Formoterol, Salmeterol
Corticosteroids:

Beclometasone, Budesonide, Fluticasone

Leukotriene antagonists:

Montelukast, Pranlukast, Zafirlukast

Xanthines:

Aminophylline, Theobromine, Theophylline

Mast cell stabilizers:

Cromoglicate, Nedocromil

Combination products:

Budesonide/formoterol, Fluticasone/salmeterol, Ipratropium/salbutamol